JOHANNESBURG, 29 November 2013 (IRIN) - The world's largest antiretroviral (ARV) programme is in crisis. One in five health facilities in South Africa reported a stock-out of antiretroviral (ARV) or tuberculosis (TB) medication in the past three months, putting the lives of many patients in jeopardy, according to activists. 

The stakes are dangerously high: over 2.4 million people are receiving ARVs at public sector facilities, while the TB programme treats over 300,000 people every year...

This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now